BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8013874)

  • 1. Effect of growth temperature on complement-mediated killing of mesophilic Aeromonas spp. serotype O:34.
    Merino S; Alvarez D; Hernández-Allés S; Tomás JM
    FEMS Microbiol Lett; 1994 May; 118(1-2):163-6. PubMed ID: 8013874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aeromonas salmonicida resistance to complement-mediated killing.
    Merino S; Albertí S; Tomás JM
    Infect Immun; 1994 Dec; 62(12):5483-90. PubMed ID: 7525485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of lipopolysaccharide in complement-killing of Aeromonas hydrophila strains of serotype O:34.
    Merino S; Camprubí S; Tomás JM
    J Gen Microbiol; 1991 Jul; 137(7):1583-90. PubMed ID: 1955853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing.
    Merino S; Camprubí S; Albertí S; Benedí VJ; Tomás JM
    Infect Immun; 1992 Jun; 60(6):2529-35. PubMed ID: 1587619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesophilic Aeromonas sp. serogroup O:11 resistance to complement-mediated killing.
    Merino S; Rubires X; Aguilar A; Albertí S; Hernandez-Allés S; Benedí VJ; Tomas JM
    Infect Immun; 1996 Dec; 64(12):5302-9. PubMed ID: 8945581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement resistance of capsulated strains of Aeromonas salmonicida.
    Merino S; Aguilar A; Tomás JM; Bonet R; Martinez MJ; Simón-Pujol D; Congregado F
    Microb Pathog; 1997 May; 22(5):315-20. PubMed ID: 9160301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesophilic Aeromonas strains from different serogroups: the influence of growth temperature and osmolarity on lipopolysaccharide and virulence.
    Merino S; Aguilar A; Rubires X; Tomás JM
    Res Microbiol; 1998 Jun; 149(6):407-16. PubMed ID: 9766240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing.
    Joiner K; Brown E; Hammer C; Warren K; Frank M
    J Immunol; 1983 Feb; 130(2):845-9. PubMed ID: 6848598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
    Joiner KA; Tartanian AB; Hammer CH; Schweinle JE
    J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Profiling Reveals Distinct Routes To Complement Resistance in Klebsiella pneumoniae.
    Short FL; Di Sario G; Reichmann NT; Kleanthous C; Parkhill J; Taylor PW
    Infect Immun; 2020 Jul; 88(8):. PubMed ID: 32513855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable insertion of C5b-9 complement complexes into the outer membrane of serum treated, susceptible Escherichia coli cells as a prerequisite for killing.
    Kroll HP; Voigt WH; Taylor PW
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec; 258(2-3):316-26. PubMed ID: 6397947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the susceptibility of Pseudomonas aeruginosa to complement-mediated killing: role of antibodies to the rough lipopolysaccharide on serum-sensitive strains.
    Schiller NL
    Infect Immun; 1988 Mar; 56(3):632-9. PubMed ID: 3125110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide phase variation determines the complement-mediated serum susceptibility of Coxiella burnetii.
    Vishwanath S; Hackstadt T
    Infect Immun; 1988 Jan; 56(1):40-4. PubMed ID: 3335408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of Actinobacillus pleuropneumoniae to bactericidal antibody and complement is mediated by capsular polysaccharide and blocking antibody specific for lipopolysaccharide.
    Ward CK; Inzana TJ
    J Immunol; 1994 Sep; 153(5):2110-21. PubMed ID: 8051416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of osmolarity on lipopolysaccharides and virulence of Aeromonas hydrophila serotype O:34 strains grown at 37 degrees C.
    Aguilar A; Merino S; Rubires X; Tomas JM
    Infect Immun; 1997 Apr; 65(4):1245-50. PubMed ID: 9119458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
    Tesh VL; Duncan RL; Morrison DC
    J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice.
    Fu X; Ju J; Lin Z; Xiao W; Li X; Zhuang B; Zhang T; Ma X; Li X; Ma C; Su W; Wang Y; Qin X; Liang S
    Sci Rep; 2016 Jul; 6():30239. PubMed ID: 27444648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.